Posted on 3/25/19
Bioelectronic Medicine Study to Improve Hearing Restoration Receives $9.7M NIH Grant
Loren Rieth, PhD, a professor at the Feinstein Institute for Medical Research and leading researcher in the field of bioelectronic medicine, will collaborate with a global . . .
Posted on 3/25/19
Seabrook Unveils New Fitness Center
Seabrook, an Erickson Living developed and managed retirement community in Tinton Falls, New Jersey, unveiled its newly renovated in-house fitness center at a ribbon cutting ceremony . . .
Posted on 3/21/19
Cellular Biomedicine Group Announces Pricing of Public Offering of Common Stock
Cellular Biomedicine Group, Inc. (Nasdaq: CBMG), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today . . .
Posted on 3/21/19
HENRY The Dentist Raises $10 Million
HENRY The Dentist (HENRY) announced the closing of a $10 million Series A financing, led by Forerunner Ventures, to expand its fleet of mobile dental practices
Posted on 3/21/19
Celgene Presents An Attractive Short-Term Investment Opportunity In March 2019
SummaryCelgene continues to trade at a significant discount to Bristol-Myers Squibb’s offer price.The probability of completion of acquisition of Celgene by Bristol-Myers Squibb is high.Bristol-Myers Squibb . . .
Posted on 3/21/19
Buy Cigna At A Discount
Summary Cigna reported strong fourth quarter earnings that markets quickly ignored. Selling pressure pushed the stock lower after the Express Scripts deal. Stock trades at a . . .
Posted on 3/20/19
Emisphere Development Update
ROSELAND, N.J., March 20, 2019 (GLOBE NEWSWIRE) -- Novo Nordisk announced today it has submitted two New Drug Applications to the US Food and Drug Administration for . . .
Posted on 3/20/19
Petra Pharma Announces Licensing Agreement With Takeda Pharmaceutical Company
Petra Pharma Corporation, a leader in phosphoinositide (PI) signaling pathway inhibition, announced it has secured a global license from Takeda Pharmaceutical Company Limited to develop, manufacture . . .
Posted on 3/20/19
Dr. Dennis Gross Skincare Announces New Partnership With Bisous For Léo
Dr. Dennis Gross Skincare announces its important partnership with Bisous For Léo, continuing its goal to positively impact families and communities through philanthropic efforts. Through this . . .
Posted on 3/20/19
Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022
KENILWORTH, N.J., and SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that . . .
Posted on 3/20/19
Pfizer To Acquire Vivet Therapeutics
Vivet Therapeutics, a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need
Posted on 3/20/19
Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle?
It doesn't look as if Bristol-Myers Squibb (NYSE:BMY) sought approval from its largest shareholders before offering Celgene (NASDAQ:CELG) a whopping $90 billion earlier this year.Starboard Value . . .
Posted on 3/19/19
New Study: Reusable Bronchoscopes Cost More Than Sterile Single-use Bronchoscopes
Study urges hospitals to consider obtaining sterile single-use bronchoscopes for routine procedures to improve hospital economy and patient safety. Bronchoscopes – one of the most commonly . . .
Posted on 3/19/19
MHA Recognized as a Best Place to Work in NJ
Managed Health Care Associates, Inc. (MHA), a leading health care services and software company focused on the alternate site health care provider marketplace, is honored and . . .
Posted on 3/19/19
One Drop Partners With Amazon's Choice
One Drop, a leader in the development of digital therapeutics solutions for people with diabetes and related conditions, today announced a partnership with Amazon's exclusive health . . .
Posted on 3/18/19
TYME Announces Leadership Team Update
NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies, announced a realignment in responsibilities . . .
Posted on 3/18/19
Cognizant Modernizes EmblemHealth Legacy Systems
Cognizant (Nasdaq: CTSH) announced its work with New York City based health insurance provider EmblemHealth, one of the largest non-profit health insurers in the U.S., to . . .
Posted on 3/18/19
Pfizer Venture Investments Joins $63M Series B For Imara
Imara Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD) and other hemoglobinopathies, today announced the closing of an oversubscribed $63 million
Posted on 3/18/19
OrbiMed Advisors Co-led $63M Series B For Imara
Imara Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD) and other hemoglobinopathies, today announced the closing of an oversubscribed $63 million
Posted on 3/18/19
For Bristol-Myers Squibb's Sake, Celgene Merger Should Be Voted Down
Summary Celgene has been struggling in its oncology segment. 23% of assets are in goodwill, with the risk of a writedown. Starboard Value is calling shenanigans . . .
Posted on 3/18/19
Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?
Bristol-Myers Squibb (NYSE:BMY) shocked everybody when it announced its $74 billion acquisition of Celgene (NASDAQ:CELG) earlier this year. Not everyone was happy, with the merger drawing . . .
Posted on 3/18/19
Matinas BioPharma Prices Public Offering of Common Stock
BEDMINSTER, N.J.--(BUSINESS WIRE)--Matinas BioPharma Holdings, Inc. -- (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company, today announced the pricing of its underwritten registered public offering of 27,272,727 shares . . .
Posted on 3/17/19
Outlook Therapeutics Announces Reverse Stock Split
CRANBURY, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) announced today that its Board of Directors has approved a 1-for-8 reverse stock . . .
Posted on 3/15/19
Matinas BioPharma Announces Proposed Public Offering of Common Stock
BEDMINSTER, N.J.--(BUSINESS WIRE)--Matinas BioPharma Holdings, Inc. -- (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of its common stock. . . .
Posted on 3/14/19
Bellerophon Provides Business Update
WARREN, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results . . .

